What is the recommended treatment for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Cellulitis

For typical cases of cellulitis without systemic signs of infection, a 5-day course of antibiotics active against streptococci is recommended as the first-line treatment. 1

Antibiotic Selection Algorithm

Mild Uncomplicated Cellulitis (outpatient treatment)

  • First-line therapy: Antibiotics active against streptococci
    • Penicillin (250-500 mg every 6 hours orally)
    • Amoxicillin (500 mg three times daily)
    • Cephalexin (500 mg every 6 hours orally)
    • Clindamycin (300-450 mg every 6-8 hours orally) for penicillin-allergic patients

Moderate Cellulitis with Systemic Signs

  • Add coverage for methicillin-susceptible S. aureus (MSSA)
    • Dicloxacillin (500 mg every 6 hours orally)
    • Cephalexin (500 mg every 6 hours orally)
    • Clindamycin (300-450 mg every 6-8 hours orally)

Severe Cellulitis or Special Circumstances

  • Consider MRSA coverage if any of the following risk factors:

    • Penetrating trauma
    • Evidence of MRSA infection elsewhere
    • MRSA nasal colonization
    • Injection drug use
    • Systemic inflammatory response syndrome (SIRS)
    • Purulent drainage
  • MRSA coverage options:

    • Vancomycin (15 mg/kg every 12 hours IV)
    • Linezolid (600 mg every 12 hours IV or orally)
    • Doxycycline (100 mg twice daily)
    • Trimethoprim-sulfamethoxazole (1-2 DS tablets twice daily)
  • For severely compromised patients (malignancy on chemotherapy, neutropenia, severe immunodeficiency):

    • Vancomycin plus piperacillin-tazobactam or imipenem/meropenem

Duration of Treatment

  • 5-day course is recommended for uncomplicated cellulitis 1, 2
  • Extend treatment if infection has not improved after 5 days 1

Adjunctive Measures

  1. Elevation of the affected area to reduce edema 1
  2. Treatment of predisposing factors such as:
    • Edema
    • Underlying skin disorders
    • Venous insufficiency
    • Toe web abnormalities 1
  3. Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults to reduce inflammation 1

Hospitalization Criteria

Hospitalize patients with:

  • Systemic inflammatory response syndrome (SIRS)
  • Altered mental status
  • Hemodynamic instability
  • Concern for deeper or necrotizing infection
  • Poor adherence to therapy
  • Severe immunocompromise
  • Failure of outpatient treatment 1

Management of Recurrent Cellulitis

  1. Identify and treat predisposing conditions (edema, obesity, eczema, venous insufficiency, toe web abnormalities) 1
  2. For frequent recurrences (3-4 episodes per year):
    • Consider prophylactic antibiotics:
      • Oral penicillin or erythromycin twice daily for 4-52 weeks
      • Intramuscular benzathine penicillin every 2-4 weeks 1

Common Pitfalls and Caveats

  1. Misdiagnosis: Many conditions mimic cellulitis including venous stasis dermatitis, contact dermatitis, and lymphedema 3
  2. Unnecessary MRSA coverage: Most non-purulent cellulitis is caused by streptococci and does not require MRSA coverage 1, 3
  3. Excessive treatment duration: 5 days is sufficient for most cases; longer courses don't improve outcomes but increase antibiotic resistance risk 1, 2
  4. Failure to examine interdigital spaces in lower extremity cellulitis, which can harbor pathogens causing recurrent infection 1
  5. Overlooking underlying conditions that predispose to cellulitis and recurrence 1, 4

By following this evidence-based approach to cellulitis treatment, clinicians can effectively manage this common infection while minimizing unnecessary antibiotic use and reducing the risk of complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.